Website Error

Please browse the list below to see if you may be able to locate it under a different name.

BSIs and the NHSN: What Are We Learning?

1. Gain practical insights regarding the CDC's NHSN as a tool for public reporting of central line-associated BSI data and its role in measuring outcomes and improving performance in your organization.
2. Identify the usefulness and advantages of NHSN as a comparative tool for BSI rates. and its role in clinical practice.
3. Define the challenges and issues of this system and plans to address these.
4. Understand the lessons learned so far from NHSN that relate specifically to BSI and what is expected with continued use of the system.

Mandatory Reporting of BSIs: Are We Improving Outcomes?

1. Provide an overview of the current state of mandatory reporting from the regulatory viewpoint in the state of Pennsylvania (first state public reporting)
2. Address what are the state-based reporting initiatives telling us?
3. Identify the lessons learned/implications relative to the outcomes achieved within your BSI prevention program at UPMC

The Joint Commission Standards and National Patient Safety Goals: Guidance for BSI Prevention, Monitoring and Outcomes

• Discuss the evolution and formation of National Patient Safety Goals (NPSG)
• Describe the formation of these three NPSGs.
  • NPSG: 07.03.01: Implement Evidence-based Practices to Prevent Health Care Associated Infections Due to Multiple Drug-resistant Organisms in Acute Care Hospitals
  • NPSG.07.04.01: Implement Best Practices or Evidence-based Guidelines to Prevent Central Line-Associated Bloodstream Infections
  • NPSG.07.05.01: Implement Best Practices for Preventing Surgical Site Infections
• Delineate specific accreditation expectations for NPSG.07.04.01

Why are Vascular Devices Prone to Biofilm Contamination?

1. Explain the obstacles to preventing, managing and eradicating biofilms in vascular access devices.
2. Identify clinical strategies to reduce the impact of biofilm.

Central Line Associated Blood Stream Infections (CLABSI) Education and the Community Hospital

1. Review the significant impact on hospitals and adverse outcomes for patients caused by CLABSIs
2. Provide an overview of how educational programs decrease the risk of CLABSI and describe an educational program created by the Duke Infection Control Outreach Network (DICON)
3. Address the unique impact that CLABSIs have on community hospitals

Frequently Asked Questions with the DICON team

Looking to the Future: New Technologies in the Prevention of Biofilm Contamination in Vascular Access Devices

1. Explain key recent research related to biofilms: medical devices in general & vascular access in particular
2. Identify areas of future investigation and potential new solutions being tested.

The Joint Commission Standards and National Patient Safety Goals: Guidance for BSI Prevention, Monitoring and Outcomes On-Demand

• Discuss the evolution and formation of National Patient Safety Goals (NPSG)
• Describe the formation of these three NPSGs.
  • NPSG: 07.03.01: Implement Evidence-based Practices to Prevent Health Care Associated Infections Due to Multiple Drug-resistant Organisms in Acute Care Hospitals
  • NPSG.07.04.01: Implement Best Practices or Evidence-based Guidelines to Prevent Central Line-Associated Bloodstream Infections
  • NPSG.07.05.01: Implement Best Practices for Preventing Surgical Site Infections
• Delineate specific accreditation expectations for NPSG.07.04.01

CLABSI Prevention Strategies:
Understanding the Risks of Peripherally Inserted Central Catheters

1. Describe PICC utilization trends and associated infection risks and rates.
2. Identify key strategies to reduce risk of CABSI when using PICCs.
3. Explain how the environment of care can impact infections associated with PICCs and other long term catheters.
4. Review the results of PICC teams and PICC contracted service providers in achieving optimum device-associated outcomes.

Aiming for Zero CABSIs:
Best Practices in Multiple Sites of Care

1. Discuss specific elements of performance for NPSG 07.04.01
2. Review the timeline for implementation
3. Describe strategies and tools for community hospitals to achieve compliance with NPSG 07.04.01
4. Describe strategies that can be implemented by outpatient/ambulatory centers in their CABSI prevention programs

Caring for the Patient with a Central Vascular Access Device (CVAD): the Basics and Beyond

1. Discuss resources that are available to assist with development of institutional protocols for central vascular access device (CVAD) care and maintenance.
2. Describe at least three measures used to prevent infections related to CVADs.
3. Explain the role of education of personnel and patients in preventing infections in patients with a CVAD.

Promoting Change to Prevent CABSIs

1. Define organizational change
2. Discuss the current state of organizational change in health care as it relates to CABSI
3. Identify methods to promote change and develop reliable processes to prevent CABSI

Building an IV Cart for the Prevention of CABSIs

1. State at least three reasons for (or benefits of) using IV carts and kits
2. Discuss the steps in developing, implementing and maintaining an IV cart
3. List the basic components of an IV cart

Needleless Connectors: Sorting Out the Differences

1. Review the external and internal characteristics of needleless connectors.
2. Explain the functionality of current types of needleless connectors.
3. Describe the appropriate flushing methods for each type of needleless connector.

Taking IV Bundles to the Next Level: Practical Methods for Monitoring and Measuring Compliance to Improve CABSI Prevention Performance

1. Demonstrate knowledge of the processes that prevent catheter associated bloodstream infections
2. Describe the importance of measuring compliance
3. Discuss the rationale for providing compliance data and findings to healthcare personnel and administrators
4. Review methods for monitoring, measuring and reporting compliance

Needleless Connectors: Do They Play a Role in Catheter-Associated Bloodstream Infections (CABSIs)?

1. Discuss at least two reports of increased rates of bloodstream infection associated with the use of needleless connectors.
2. List at least three risk factors for catheter-related bloodstream infections associated with needleless connectors.
3. Describe at least three measures that can be used to reduce the risk of bloodstream infections associated with needleless connectors.